Format

Send to

Choose Destination
Am J Respir Crit Care Med. 2010 Dec 1;182(11):1344-51. doi: 10.1164/rccm.201001-0038PP. Epub 2010 Aug 13.

Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research.

Author information

1
University of Miami Miller School of Medicine, Florida 33136, USA. awanner@miami.edu

Abstract

Endothelial dysfunction in the extrapulmonary circulation has been linked to cardiovascular disease. Recent investigations have revealed that in the airway circulation, cigarette smoking, chronic obstructive pulmonary disease (COPD), and asthma are also accompanied by endothelial dysfunction. Inhaled glucocorticosteroids can partially or fully restore normal endothelium-dependent vasodilation in these conditions, thereby identifying the airway endothelium as a novel therapeutic target in the treatment of airway disease. The role of the defective endothelium-dependent vasodilation in the pathophysiology in asthma and COPD is still subject to speculation. However, there appears to be an association between COPD and extrapulmonary vascular dysfunction, and the possibility exists that the use of inhaled glucocorticosteroids has a beneficial effect on cardiovascular disease in COPD as suggested by database studies showing that inhaled glucocorticosteroids reduce the incidence of nonfatal and fatal cardiovascular events in COPD.

PMID:
20709816
DOI:
10.1164/rccm.201001-0038PP
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center